Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...
By studying the genes responsible for the seahorse’s brood pouch, researchers uncovered a new route to “motherhood.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback